Publications by authors named "Thomas Melchardt"

57Publications

Austrian recommendations for the management of essential thrombocythemia.

Wien Klin Wochenschr 2020 Nov 19. Epub 2020 Nov 19.

Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-020-01761-3DOI Listing
November 2020

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.

J Clin Med 2020 Jun 1;9(6). Epub 2020 Jun 1.

Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Department of Internal Medicine III with Haematology, Salzburg Cancer Research Institute, Oncologic Center Salzburg, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9061663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355487PMC
June 2020

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.

Int J Mol Sci 2020 Apr 19;21(8). Epub 2020 Apr 19.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21082856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215892PMC
April 2020

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

Oncol Lett 2020 Feb 9;19(2):1551-1558. Epub 2019 Dec 9.

IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, A-5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2019.11192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956108PMC
February 2020

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.

J Clin Med 2019 Oct 25;8(11). Epub 2019 Oct 25.

rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University, 5071 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8111791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912559PMC
October 2019

Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.

Clin Colorectal Cancer 2019 06 11;18(2):159-166.e3. Epub 2019 Apr 11.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology, and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute, Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15330028183055
Publisher Site
http://dx.doi.org/10.1016/j.clcc.2019.04.003DOI Listing
June 2019

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.

Eur J Haematol 2019 May 28;102(5):437-441. Epub 2019 Feb 28.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster Salzburg, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849823PMC
May 2019

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.

Cancer Med 2018 12 10;7(12):5962-5972. Epub 2018 Nov 10.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308077PMC
December 2018

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.

PLoS One 2018 9;13(11):e0206688. Epub 2018 Nov 9.

IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0206688PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226156PMC
April 2019

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

BMC Cancer 2018 Nov 6;18(1):1074. Epub 2018 Nov 6.

IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-
Publisher Site
http://dx.doi.org/10.1186/s12885-018-4979-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220453PMC
November 2018

Remission maintenance treatment options in chronic lymphocytic leukemia.

Cancer Treat Rev 2018 Nov 10;70:56-66. Epub 2018 Aug 10.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Austria; Salzburg Cancer Research Institute and Cancer Cluster Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.08.003DOI Listing
November 2018

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

Wien Klin Wochenschr 2018 Sep 24;130(17-18):495-504. Epub 2018 Jul 24.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-018-1365-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132876PMC
September 2018

Austrian recommendations for the management of polycythemia vera.

Wien Klin Wochenschr 2018 Sep 19;130(17-18):535-542. Epub 2018 Jul 19.

Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-018-1359-3DOI Listing
September 2018

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

Eur J Cancer 2018 04 20;93:69-78. Epub 2018 Mar 20.

IIIrd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria; Salzburg Cancer Research Institute, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183007
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.01.064DOI Listing
April 2018

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.

Memo 2017 20;10(4):220-223. Epub 2017 Oct 20.

Third Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0358-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725515PMC
October 2017

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.

Blood 2017 01 22;129(3):383-385. Epub 2016 Nov 22.

Clinical Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-06-720599DOI Listing
January 2017

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.

Wien Klin Wochenschr 2017 Feb;129(3-4):141-144

IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumathology, Oncologic Center, Paracelsus Medical University, Muellner Hauptstraße 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-016-1124-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318479PMC
February 2017

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.

J Clin Oncol 2016 07 9;34(20):2433-4. Epub 2016 May 9.

Paracelsus Medical University Salzburg; Salzburg Cancer Research Institute; and Cancer Cluster Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.6057DOI Listing
July 2016

Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.

BMC Cancer 2015 Dec 22;15:996. Epub 2015 Dec 22.

Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research and Center for Clinical Cancer and Immunology Trials, Paracelsus Medical University Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-2020-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687318PMC
December 2015

Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.

J Natl Compr Canc Netw 2015 Dec;13(12):1501-8

From the Department of Internal Medicine III, Cancer Research Institute, Paracelsus Medical University Salzburg, Salzburg, Austria; Division of Hematology, Medical University of Graz, Graz, Austria; Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria; and Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Duarte, Texas.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/13/12/1501.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2015.0178DOI Listing
December 2015

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.

Blood 2015 Oct 10;126(15):1762-9. Epub 2015 Aug 10.

Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-04-637280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608390PMC
October 2015

Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.

Ann Hematol 2015 Apr 13;94(4):593-601. Epub 2014 Nov 13.

Department of Internal Medicine V (Haematology and Oncology), Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2250-6DOI Listing
April 2015

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Neuropathol Appl Neurobiol 2015 Feb;41(2):e41-55

Institute of Neurology, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center CNS Tumors Unit, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nan.12185DOI Listing
February 2015

Kasabach-Merritt phenomenon in hepatic angiosarcoma.

Br J Haematol 2014 Dec 24;167(5):716-8. Epub 2014 Jul 24.

IIIrd Medical Department, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13049DOI Listing
December 2014

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.

Leuk Lymphoma 2015 Feb 25;56(2):353-60. Epub 2014 Jun 25.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.916798DOI Listing
February 2015

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs.

BMC Complement Altern Med 2014 Mar 30;14:115. Epub 2014 Mar 30.

Department of Internal Medicine III, Salzburg Cancer Research Institute, Paracelsus Medical University Salzburg, Austria, Müllner-Hauptstrasse 48, Salzburg 5020, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6882-14-115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994275PMC
March 2014

Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.

Ann Hematol 2014 Mar 18;93(3):459-62. Epub 2014 Jan 18.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Salzburger Landeskliniken, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2009-0DOI Listing
March 2014

Pleural decortication of a marginal zone lymphoma.

Ann Hematol 2014 Jul 22;93(7):1253-4. Epub 2013 Nov 22.

Department of Internal Medicine III, Salzburg Cancer Research Institute, Paracelsus Medical University, Müllner-Hauptstrasse 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/1250c13ecd37cf51a400e18e
Web Search
http://link.springer.com/10.1007/s00277-013-1960-5
Publisher Site
http://dx.doi.org/10.1007/s00277-013-1960-5DOI Listing
July 2014

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.

Oncol Lett 2013 Dec 15;6(6):1756-1758. Epub 2013 Oct 15.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncological Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University of Salzburg, Salzburg A-5020, Austria.

View Article

Download full-text PDF

Source
https://www.spandidos-publications.com/10.3892/ol.2013.1629
Publisher Site
http://dx.doi.org/10.3892/ol.2013.1629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834563PMC
December 2013

Viral infections and their management in patients with chronic lymphocytic leukemia.

Leuk Lymphoma 2013 Aug 3;54(8):1602-13. Epub 2013 Jan 3.

Third Medical Department of Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Paracelsus Medical University and Laboratory for Immunological and Molecular Cancer Research (LIMCR), Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.755178DOI Listing
August 2013

Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.

J Clin Oncol 2011 Aug 5;29(24):e696-8. Epub 2011 Jul 5.

University Hospital Salzburg of the Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.8283DOI Listing
August 2011

Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.

Cancer 2011 May 18;117(10):2163-9. Epub 2010 Nov 18.

Laboratory for Immunological and Molecular Cancer Research, Third Medical Department With Hematology, Medical Oncology, Hemostaseology, Rheumatology, and Infectious Disease of the Private Medical University Hospital of Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25752DOI Listing
May 2011

An uncommon cause of anaemia: Sheehan's syndrome.

Wien Klin Wochenschr 2010 Dec 7;122(23-24):717-9. Epub 2010 Dec 7.

IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Rheumatology, Infectious Disease of the Private Medical University Hospital Laboratory for Immunological and Molecular Cancer Research, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-010-1480-4DOI Listing
December 2010

[Implementation of evidence based medicine in primary care].

Wien Med Wochenschr 2009 ;159(7-8):207-10

Institut für Allgemein-, Familien- und Präventivmedizin, Paracelsus Medizinische Privatuniversität, Salzburg, Osterreich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10354-009-0673-9DOI Listing
October 2009